Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000061

Chief Operating Officer sold 600 shares at $69.69 ($41,814)

From the SEC's structured data for this filing

Trades in this filing

Sandler Laura Lee · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form −600 $69.69 $41,814 236,384 D
Open-market sales · 600 sh · avg $69.69 · $41,814
Loading xslF345X06/form4.xml…